These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 196039

  • 1. Antiviral activity in the rabbit cornea of adenine arabinoside, Ara-A 5' monophosphate, and hypoxanthine arabinoside; and interactions with adenosine deaminase inhibitor.
    Falcon MG, Jones BR.
    J Gen Virol; 1977 Jul; 36(1):199-202. PubMed ID: 196039
    [Abstract] [Full Text] [Related]

  • 2. Antiviral activity of an adenosine deaminase inhibitor: decreased replication of herpes simplex virus.
    Williams BB, Lerner AM.
    J Infect Dis; 1975 Jun; 131(6):673-7. PubMed ID: 166117
    [Abstract] [Full Text] [Related]

  • 3. Anti-herpes activity of adenine arabinoside monophosphate.
    Trobe JD, Centifanto Y, Zam ZS, Varnell E, Kaufman HE.
    Invest Ophthalmol; 1976 Mar; 15(3):196-9. PubMed ID: 1254407
    [Abstract] [Full Text] [Related]

  • 4. Antiherpesvirus activity in human sera and urines after administration of adenine arabinoside: in vitro and in vivo synergy of adenine arabinoside and arabinosylhypoxanthine in combination.
    Champney KJ, Lauter CB, Bailey EJ, Lerner AM.
    J Clin Invest; 1978 Dec; 62(6):1142-53. PubMed ID: 219024
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Ara AMP- a highly soluble new antiviral drug.
    Pavan-Langston D, North RD, Geary PA.
    Ann Ophthalmol; 1976 May; 8(5):571-9. PubMed ID: 937940
    [Abstract] [Full Text] [Related]

  • 7. Antiviral activity of arabinosyladenine and arabinosylhypoxanthine in herpes simplex virus-infected KB cells: selective inhibition of viral deoxyribonucleic acid synthesis in the presence of an adenosine deaminase inhibitor.
    Schwartz PM, Shipman C, Drach JC.
    Antimicrob Agents Chemother; 1976 Jul; 10(1):64-74. PubMed ID: 185947
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of the antiviral effects of 5-methoxymethyldeoxyuridine-5'-monophosphate with adenine arabinoside-5'-monophosphate.
    Ayisi NK, Meldrum JB, Stuart AL, Gupta VS.
    Antiviral Res; 1983 Sep; 3(3):161-74. PubMed ID: 6197027
    [Abstract] [Full Text] [Related]

  • 10. Herpes simplex keratitis: animal models to guide the selection and optimal delivery of antiviral chemotherapy.
    Falcon MG, Jones BR.
    J Antimicrob Chemother; 1977 Mar; 3 Suppl A():83-9. PubMed ID: 863807
    [No Abstract] [Full Text] [Related]

  • 11. Anti-herpesvirus activity of adenine arabinoside analogues in tissue culture and a genital infection of mice and guinea pigs.
    Richards JT, Kern ER, Overall JC, Glasgow LA.
    Antiviral Res; 1982 May; 2(1-2):27-39. PubMed ID: 6179469
    [Abstract] [Full Text] [Related]

  • 12. Viral keratitis-inhibitory effect of 9-beta-D-arabinofuranosylhypoxanthine 5'-monophosphate.
    Sidwell RW, Allen LB, Huffman JH, Revankar GR, Robins RK, Tolman RL.
    Antimicrob Agents Chemother; 1975 Oct; 8(4):463-7. PubMed ID: 1190753
    [Abstract] [Full Text] [Related]

  • 13. Chemotherapy of herpetic keratitis induced by acyclovir-resistant strains of herpes simplex virus type 1.
    O'Brien WJ, Taylor JL.
    Am J Med; 1982 Jul 20; 73(1A):294-9. PubMed ID: 6285720
    [Abstract] [Full Text] [Related]

  • 14. Latent herpes simplex virus infections in sensory ganglia of mice after topical treatment with adenine arabinoside and adenine arabinoside monophosphate.
    Klein RJ, Friedman-Kien AE.
    Antimicrob Agents Chemother; 1977 Nov 20; 12(5):577-81. PubMed ID: 200172
    [Abstract] [Full Text] [Related]

  • 15. Inhibitory and lethal concentrations of 9-beta-D-arabinofuranosyladenine and its hypoxanthine-derivative versus herpes simplex virus, type 1.
    Williams BB, Bailey EJ, Lerner AM.
    J Lab Clin Med; 1977 Apr 20; 89(4):687-91. PubMed ID: 191546
    [Abstract] [Full Text] [Related]

  • 16. Erythro-9-(2-hydroxy-3-nonyl) Adenine alone and in combination with 9-beta-D-arabinofuranosyladenine in treatment of systemic herpesvirus infections in mice.
    Shannon WM, Arnett G, Schabel FM, North TW, Cohen SS.
    Antimicrob Agents Chemother; 1980 Oct 20; 18(4):598-603. PubMed ID: 6255863
    [Abstract] [Full Text] [Related]

  • 17. Metabolism and pharmacokinetics of the anti-varicella-zoster virus agent 6-dimethylaminopurine arabinoside.
    Lambe CU, Resetar A, Spector T, Koszalka GW, Nelson DJ.
    Antimicrob Agents Chemother; 1992 Feb 20; 36(2):353-60. PubMed ID: 1318679
    [Abstract] [Full Text] [Related]

  • 18. Erythro-9-(2-hydroxy-3-nonyl)adenine as a specific inhibitor of herpes simplex virus replication in the presence and absence of adenosine analogues.
    North TW, Cohen SS.
    Proc Natl Acad Sci U S A; 1978 Oct 20; 75(10):4684-8. PubMed ID: 216993
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of adenosine deaminase by co-vidarabine and its effect on the metabolic disposition of adenine arabinoside (vidarabine).
    Borondy PE, Chang T, Maschewske E, Glazko AJ.
    Ann N Y Acad Sci; 1977 Mar 04; 284():9-20. PubMed ID: 280160
    [No Abstract] [Full Text] [Related]

  • 20. Adenine arabinoside inhibition of adenovirus replication enhanced by an adenosine deaminase inhibitor.
    Wigand R.
    J Med Virol; 1979 Mar 04; 4(1):59-65. PubMed ID: 119038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.